Paquin, Ashley R.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Buadi, Francis K.
Gertz, Morie A.
Lacy, Martha Q.
Dispenzieri, Angela
Dingli, David
Hwa, Lisa
Fonder, Amie
Hobbs, Miriam
Hayman, Suzanne R.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Lin, Yi
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Warsame, Rahma
Kyle, Robert A.
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA 107476, CA 168762, CA 186781, CA 107476, CA 168762, CA 186781)
Article History
Received: 13 September 2018
Revised: 20 November 2018
Accepted: 23 November 2018
First Online: 11 December 2018
Conflict of interest
: A.D.—Celgene, Takeda, Pfizer, Prothena, and Alnylam (research funding). M.A.G.—Johnson and Johnson (honoraria). P.K.—Takeda, Amgen, and Sanofi (research funding), and Celgene and Sanofi (consulting fees). Y.L.—Janssen (research funding). S.K.K.—Abbvie, Celgene, Janssen, Merck, Novartis, Roche, Sanofi, and Takeda (research funding), and Skyline Diagnostics (honoraria). The remaining authors declare that they have no conflict of interest.